Shantha Biologics to make injectable drug cartridges for Novo Nordisk

Shantha Biologics has secured a significant contract with Danish pharmaceutical giant Novo Nordisk to manufacture cartridges for injectable medicines at its Hyderabad facility. This partnership highlights India's growing role in advanced pharmaceutical manufacturing, particularly for high-demand diabetes and obesity therapies. Shantha's FDA-approved, automated fill-finish lines will produce these critical components, underscoring the company's expanding capabilities in contract manufacturing for biologics.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/eqmNj5D
via IFTTT

Read More

Generics must not be imperiled over data protection: Satish Reddy, Chairman, Dr Reddy's Laboratories

Dr Reddy's chairman, Satish Reddy, has raised concerns about compromising India's competitive edge in generics for foreign investments. He stresses the importance of aligning capital with developmental needs and enhancing collaboration between academia and industry. Advocating for a national mission akin to China's, he highlights the necessity of structured government procurement to stimulate drug innovation and underscores AI's transformative role in drug discovery, contingent on adaptive regulatory systems.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Zy56Brh
via IFTTT

Read More

Telangana bets big on drug discovery hub

Telangana is gearing up to elevate Hyderabad's pharmaceutical standing beyond manufacturing. The state is fostering an integrated ecosystem for drug discovery and development, bringing together industry, research, startups, and investors. This strategic move aims to position Telangana as a hub for next-generation therapies, leveraging its existing strength as a global vaccine production leader.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/O9uben6
via IFTTT

Read More

Mankind Pharma partners Denovo Sciences for AI-led drug discovery

Mankind Pharma has partnered with Denovo Sciences to accelerate drug discovery using artificial intelligence. This collaboration aims to significantly cut down early research timelines, enhance the quality of potential drug candidates, and ensure only the most promising ones advance. By combining Mankind Pharma's R&D prowess with Denovo's AI platform, the companies expect to bring effective and accessible treatments to patients faster, marking a significant step in innovation-driven research.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/GtiF5H8
via IFTTT

Read More

mRNA vaccines protect against severe infectious diseases, review confirms

Billions of mRNA vaccine doses administered globally confirm their safety and effectiveness against infectious diseases, including severe COVID-19, across all age groups and health conditions. Researchers emphasize that serious side effects are rare, with benefits far outweighing risks. This technology, now proven, holds immense promise for future vaccines and personalized treatments, though equitable global access remains crucial.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/ZiMdsJ0
via IFTTT

Read More

Mankind Pharma joins hands with Denovo Sciences for AI-powered drug discovery

Mankind Pharma has joined forces with Denovo Sciences to revolutionize drug discovery using artificial intelligence. This strategic partnership aims to significantly shorten development timelines, improve the quality of potential drug candidates, and identify the most promising options. By integrating AI with human expertise, the companies are set to accelerate the delivery of effective and accessible new medicines to patients, marking a significant step forward in pharmaceutical innovation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/oHUbqxj
via IFTTT

Read More

Telangana plans drug discovery push to move Hyderabad up pharma value chain

Telangana is charting a new course to elevate Hyderabad into a global drug discovery hub. The state is fostering an integrated ecosystem by creating shared infrastructure and funding for startups and researchers. This ambitious plan aims to accelerate the development of next-generation therapies, including cell and gene therapies, by leveraging existing strengths and forging new partnerships, positioning Hyderabad for significant advancements in pharmaceutical innovation.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/Sxoj2Tm
via IFTTT

Read More